US Patent 11352403 Activatable interleukin-2 polypeptides and methods of use thereof
Patent 11352403 was granted and assigned to Werewolf Therapeutics on June, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11352403 Activatable interleukin-2 polypeptides and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
